A normal fasting glucose does not mean a normal glucose system. By the time fasting glucose drifts out of range, insulin resistance has usually been building for five to ten years.
The early signal is not in glucose. It is in the metabolic byproducts of a system that is starting to strain. Metabolomics surfaces those byproducts directly, which is why I read it on patients whose conventional labs look clean and whose biology does not feel clean.
What the panel actually shows
When I read a metabolomics panel for glucose dysregulation, I am looking at four patterns:
- The fuel mix. A healthy mitochondrial system burns fat and carbohydrate cleanly. A strained system produces excess lactate and pyruvate even at rest. Both show up on an organic acids panel and tell me the cells are running on inefficient anaerobic metabolism.
- Branched-chain amino acids. Elevated leucine, isoleucine, and valine on a fasting panel correlate strongly with insulin resistance, often years before HbA1c shifts.
- Adipokine shifts. The fat-derived signaling molecules change pattern as insulin resistance develops. The pattern is readable.
- Inflammatory metabolites. Insulin resistance and inflammation are coupled. A panel that shows oxidative stress markers alongside metabolic ones tells me the system has been straining longer than the patient realizes.
Why fasting insulin matters more than fasting glucose
Insulin moves before glucose. Years before your fasting glucose rises, your body compensates by producing more insulin to keep glucose in range. A fasting insulin above the optimal range (I want under 7 mIU/L) is the earliest reliable signal that the system is straining.
Most conventional panels do not include fasting insulin. They check glucose and HbA1c and call it a metabolic screen. By that standard, the patient looks fine right up until they do not. I order fasting insulin on almost every patient who comes through the practice for that reason.
What this means for intervention
The single highest-leverage intervention for early insulin resistance is not a medication. It is muscle.
Skeletal muscle is the largest glucose-disposal site in the body. A well-muscled adult clears glucose without needing to spike insulin. A sarcopenic adult does not, and that compensation is most of what insulin resistance is.
The interventions, in order of leverage:
- Strength train twice a week minimum. Resistance training is the biggest single move on insulin sensitivity available without medication.
- Walk after meals. Even ten minutes of walking after a meal blunts the postprandial glucose spike measurably.
- Time-restricted eating. A 10 to 12 hour daily window. Most of the benefit is in the consistency, not in the length.
- Reduce ultra-processed food. Not perfection. Just shifting the ratio so whole foods are the default.
- Sleep. A single bad night measurably reduces insulin sensitivity the next day. Most insulin resistance has a sleep component the patient has not connected.
When medication enters the picture
I prescribe metformin when the data warrants it and the lifestyle work has been given a real try. I prescribe a GLP-1 when the case calls for it and the metabolic picture justifies it. I do not lead with medication. I do not refuse medication on principle either.
The point is to address the system, not the number. Most patients who get to fasting hyperglycemia have years of inputs they can change first. Some patients have a clear case for medication on top of those changes. The panel tells me which.
Where to start
If you have a family history of type 2 diabetes, a fasting glucose that has crept up year over year, weight that has shifted, or energy that crashes between meals, the metabolic system is worth reading directly. The path in is the Precision Call. I will tell you what I see and what panel I would order to confirm it.
